Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rachelle Suzanne Jacques Insider Profile
4 Followers
Rachelle Suzanne Jacques, Director at Corbus Pharmaceuticals, holds 2.78K shares in Corbus Pharmaceuticals (Ticker: CRBP), holds ― shares in Viela Bio (Ticker: VIE), holds 22.49K shares in uniQure (Ticker: QURE).
Rachelle Suzanne Jacques Corbus Pharmaceuticals (CRBP)Director
Corbus Pharmaceuticals (CRBP)
Director
Ranked #83,441 out of 100,202 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
-37.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Rachelle Suzanne Jacques holds in companies
Most Profitable Insider Trade
The most profitable trade made by Rachelle Suzanne Jacques
Rachelle Suzanne Jacques's Trading History
Corbus Pharmaceuticals
Jun 03, 2024
Director
Uninformative Buy
―
$36.18K
Viela Bio
―
―
―
―
uniQure
Jun 21, 2024
Director
Uninformative Buy
―
$381.85K
Akari Therapeutics
Apr 30, 2024
Chief Executive Officer, Director
Uninformative Buy
―
$987.49M
List of latest transactions for each holding click on a transaction to see Rachelle Suzanne Jacques's performance on stock
You May Also Like
Rachelle Suzanne Jacques insider profile FAQ
What is the percentage of profitable transactions made by Rachelle Suzanne Jacques?
The percentage of profitable transactions made by Rachelle Suzanne Jacques is 67%.
What is the average return per transaction made by Rachelle Suzanne Jacques?
The average return per transaction made by Rachelle Suzanne Jacques is -37.10%.
What stocks does Rachelle Suzanne Jacques hold?
Rachelle Suzanne Jacques holds: CRBP, VIE, QURE, AKTX stocks.
What was Rachelle Suzanne Jacques’s latest transaction?
Rachelle Suzanne Jacques latest transaction was an Uninformative Buy of ―.
What was Rachelle Suzanne Jacques's most profitable transaction?
Rachelle Suzanne Jacques’s most profitable transaction was an Informative Sell of QURE stock on June 20, 2023. The return on the trade was 76.50%.
What is Rachelle Suzanne Jacques's role in Corbus Pharmaceuticals?
Rachelle Suzanne Jacques's role in Corbus Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.